Biotech company taps IRG to raise profile

SAN DIEGO: OncoSec Medical, a biotechnology company, hired the Investor Relations Group (IRG) as its PR and IR agency. The company is developing treatments for skin cancer and other cancers. IRG plans to target portfolio managers and equity analysts to raise awareness of OncoSec's treatments, as well conduct a media outreach campaign targeted at relevant national trade and consumer outlets.